TERN — TERNS PHARMACEUTICALS INC

Ownership history in Persistent Asset Partners Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which Persistent Asset Partners Ltd reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.06% (2025 Q4)
Avg. % of fund
0.54%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 113,555 +39,190 +52.7% 2.06% $4.6M $40.40
2025 Q3 ADDED 74,365 +14,568 +24.4% 0.38% $558K $7.51
2025 Q2 ADDED 59,797 +46,990 +366.9% 0.17% $223K $3.73
2025 Q1 UNCHANGED 12,807 — 0% 0.03% $35K $2.76
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TERN price (monthly, adj. close)

Other funds also holding TERN

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 23.9% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 17.48% Vivo Capital, LLC 3Y 7Y 13.96% SUPERSTRING CAPITAL MANAGEMENT LP 9.6% Vestal Point Capital, LP 6.18% Ikarian Capital, LLC 3Y 5.04% Monashee Investment Management LLC 3Y 7Y 4.49% First Turn Management, LLC 4.03% Commodore Capital LP 3Y 3.97% STEMPOINT CAPITAL LP 2.97%
← Back to Persistent Asset Partners Ltd Holdings